Comparison of Gianturco Z Stents and Wallstents in a Hemodialysis Access Graft Animal Model

Scott O. Trerotola, Jeffrey H. Fair, Darrell Davidson, Michael A. Samphilipo, Carolyn A. Magee

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Purpose: To compare the primary patency of two structurally different metallic stents in an animal model of hemodialysis access grafts. Materials and Methods: Nineteen synthetic femorofemoral arteriovenous shunts were created in 10 dogs. After a 1-month period of maturation (during which one graft thrombosed), stents were placed spanning the venous anastomosis. The grafts were divided into two treatment groups (Wallstent, n = 6, and Gianturco stent, n = 6) and a control group with no stent (n = 6). Fistulograms and pressure measurements were obtained at monthly intervals for 6 months or until thrombosis of the graft. Results: Mean graft patency in the Wallstent group (112 days ± 30) was significantly shorter than in the control (157 days ± 32, P < .03) or Gianturco (157 days ± 32, P < .05) groups. Patency in the Gianturco stent group was no different from that in the control group. Stenosis due to intimal hyperplasia within the stents appeared greater in the Wallstent group but did not achieve statistical significance. One Wallstent migration, three Gianturco stent shifts, and two Gianturco stent breakages occurred. Histologic examination revealed a necrotizing vasculitis in the portion of vein containing the stent in all grafts treated with the Gianturco stent but not in any other grafts. Conclusion: In an animal model of hemodialysis access grafts, the Gianturco stent had longer primary patency than the Wallstent when placed across the venous anastomosis. However, stent fractures and focal necrotizing inflammation may limit the use of the Gianturco stent in hemodialysis access.

Original languageEnglish
Pages (from-to)387-396
Number of pages10
JournalJournal of Vascular and Interventional Radiology
Volume6
Issue number3
DOIs
StatePublished - 1995
Externally publishedYes

Fingerprint

Stents
Renal Dialysis
Animal Models
Transplants
Thrombosis
Tunica Intima
Control Groups
Vasculitis
Hyperplasia
Veins
Pathologic Constriction
Dogs
Inflammation
Pressure

Keywords

  • Dialysis, shunts, 91.494
  • Veins, grafts and prostheses, 91.494

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Comparison of Gianturco Z Stents and Wallstents in a Hemodialysis Access Graft Animal Model. / Trerotola, Scott O.; Fair, Jeffrey H.; Davidson, Darrell; Samphilipo, Michael A.; Magee, Carolyn A.

In: Journal of Vascular and Interventional Radiology, Vol. 6, No. 3, 1995, p. 387-396.

Research output: Contribution to journalArticle

Trerotola, Scott O. ; Fair, Jeffrey H. ; Davidson, Darrell ; Samphilipo, Michael A. ; Magee, Carolyn A. / Comparison of Gianturco Z Stents and Wallstents in a Hemodialysis Access Graft Animal Model. In: Journal of Vascular and Interventional Radiology. 1995 ; Vol. 6, No. 3. pp. 387-396.
@article{0dc1cd2ae1064ca98045f07af7f4528f,
title = "Comparison of Gianturco Z Stents and Wallstents in a Hemodialysis Access Graft Animal Model",
abstract = "Purpose: To compare the primary patency of two structurally different metallic stents in an animal model of hemodialysis access grafts. Materials and Methods: Nineteen synthetic femorofemoral arteriovenous shunts were created in 10 dogs. After a 1-month period of maturation (during which one graft thrombosed), stents were placed spanning the venous anastomosis. The grafts were divided into two treatment groups (Wallstent, n = 6, and Gianturco stent, n = 6) and a control group with no stent (n = 6). Fistulograms and pressure measurements were obtained at monthly intervals for 6 months or until thrombosis of the graft. Results: Mean graft patency in the Wallstent group (112 days ± 30) was significantly shorter than in the control (157 days ± 32, P < .03) or Gianturco (157 days ± 32, P < .05) groups. Patency in the Gianturco stent group was no different from that in the control group. Stenosis due to intimal hyperplasia within the stents appeared greater in the Wallstent group but did not achieve statistical significance. One Wallstent migration, three Gianturco stent shifts, and two Gianturco stent breakages occurred. Histologic examination revealed a necrotizing vasculitis in the portion of vein containing the stent in all grafts treated with the Gianturco stent but not in any other grafts. Conclusion: In an animal model of hemodialysis access grafts, the Gianturco stent had longer primary patency than the Wallstent when placed across the venous anastomosis. However, stent fractures and focal necrotizing inflammation may limit the use of the Gianturco stent in hemodialysis access.",
keywords = "Dialysis, shunts, 91.494, Veins, grafts and prostheses, 91.494",
author = "Trerotola, {Scott O.} and Fair, {Jeffrey H.} and Darrell Davidson and Samphilipo, {Michael A.} and Magee, {Carolyn A.}",
year = "1995",
doi = "10.1016/S1051-0443(95)72828-7",
language = "English",
volume = "6",
pages = "387--396",
journal = "Journal of Vascular and Interventional Radiology",
issn = "1051-0443",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Comparison of Gianturco Z Stents and Wallstents in a Hemodialysis Access Graft Animal Model

AU - Trerotola, Scott O.

AU - Fair, Jeffrey H.

AU - Davidson, Darrell

AU - Samphilipo, Michael A.

AU - Magee, Carolyn A.

PY - 1995

Y1 - 1995

N2 - Purpose: To compare the primary patency of two structurally different metallic stents in an animal model of hemodialysis access grafts. Materials and Methods: Nineteen synthetic femorofemoral arteriovenous shunts were created in 10 dogs. After a 1-month period of maturation (during which one graft thrombosed), stents were placed spanning the venous anastomosis. The grafts were divided into two treatment groups (Wallstent, n = 6, and Gianturco stent, n = 6) and a control group with no stent (n = 6). Fistulograms and pressure measurements were obtained at monthly intervals for 6 months or until thrombosis of the graft. Results: Mean graft patency in the Wallstent group (112 days ± 30) was significantly shorter than in the control (157 days ± 32, P < .03) or Gianturco (157 days ± 32, P < .05) groups. Patency in the Gianturco stent group was no different from that in the control group. Stenosis due to intimal hyperplasia within the stents appeared greater in the Wallstent group but did not achieve statistical significance. One Wallstent migration, three Gianturco stent shifts, and two Gianturco stent breakages occurred. Histologic examination revealed a necrotizing vasculitis in the portion of vein containing the stent in all grafts treated with the Gianturco stent but not in any other grafts. Conclusion: In an animal model of hemodialysis access grafts, the Gianturco stent had longer primary patency than the Wallstent when placed across the venous anastomosis. However, stent fractures and focal necrotizing inflammation may limit the use of the Gianturco stent in hemodialysis access.

AB - Purpose: To compare the primary patency of two structurally different metallic stents in an animal model of hemodialysis access grafts. Materials and Methods: Nineteen synthetic femorofemoral arteriovenous shunts were created in 10 dogs. After a 1-month period of maturation (during which one graft thrombosed), stents were placed spanning the venous anastomosis. The grafts were divided into two treatment groups (Wallstent, n = 6, and Gianturco stent, n = 6) and a control group with no stent (n = 6). Fistulograms and pressure measurements were obtained at monthly intervals for 6 months or until thrombosis of the graft. Results: Mean graft patency in the Wallstent group (112 days ± 30) was significantly shorter than in the control (157 days ± 32, P < .03) or Gianturco (157 days ± 32, P < .05) groups. Patency in the Gianturco stent group was no different from that in the control group. Stenosis due to intimal hyperplasia within the stents appeared greater in the Wallstent group but did not achieve statistical significance. One Wallstent migration, three Gianturco stent shifts, and two Gianturco stent breakages occurred. Histologic examination revealed a necrotizing vasculitis in the portion of vein containing the stent in all grafts treated with the Gianturco stent but not in any other grafts. Conclusion: In an animal model of hemodialysis access grafts, the Gianturco stent had longer primary patency than the Wallstent when placed across the venous anastomosis. However, stent fractures and focal necrotizing inflammation may limit the use of the Gianturco stent in hemodialysis access.

KW - Dialysis, shunts, 91.494

KW - Veins, grafts and prostheses, 91.494

UR - http://www.scopus.com/inward/record.url?scp=0029303282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029303282&partnerID=8YFLogxK

U2 - 10.1016/S1051-0443(95)72828-7

DO - 10.1016/S1051-0443(95)72828-7

M3 - Article

VL - 6

SP - 387

EP - 396

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

SN - 1051-0443

IS - 3

ER -